.png)
PCR-based Enteric Disease Testing Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 157 Category: Pharma & Healthcare Report Code : HC0114697
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
PCR-based Enteric Disease Testing Market By Type (Analyzers/Instruments, Kits/Panels) and Application (Clostridium Difficile, Campylobacteriosis, Cholera, E. coli Infection, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The PCR-based Enteric Disease Testing Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body's immune response, or antibodies
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global PCR-based Enteric Disease Testing Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Thermo Fisher Scientific
- Vela Diagnostics
- CorisBioconcept
- Meridian Life Science
- Bio-Rad Laboratories
- Abbott (ALERE)
- bioMerieux SA
- Trinity Biotech
- DiaSorin Molecular
- Etta Healthcare (Ovagene Oncology)
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· PCR-based Enteric Disease Testing Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Analyzers/Instruments
o Kits/Panels
· PCR-based Enteric Disease Testing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Clostridium Difficile
o Campylobacteriosis
o Cholera
o E. coli Infection
o Others
· PCR-based Enteric Disease Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Thermo Fisher Scientific
o Vela Diagnostics
o CorisBioconcept
o Meridian Life Science
o Bio-Rad Laboratories
o Abbott (ALERE)
o bioMerieux SA
o Trinity Biotech
o DiaSorin Molecular
o Etta Healthcare (Ovagene Oncology)
· PCR-based Enteric Disease Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America PCR-based Enteric Disease Testing Market, By Country
o U.S. PCR-based Enteric Disease Testing Market
o Canada PCR-based Enteric Disease Testing Market
o Mexico PCR-based Enteric Disease Testing Market
o Europe
§ Europe PCR-based Enteric Disease Testing Market, By Country
· Germany PCR-based Enteric Disease Testing Market
o UK PCR-based Enteric Disease Testing Market
o France PCR-based Enteric Disease Testing Market
o RussiaPCR-based Enteric Disease Testing Market
o Italy PCR-based Enteric Disease Testing Market
o Rest of Europe PCR-based Enteric Disease Testing Market
o Asia-Pacific
§ Asia-Pacific PCR-based Enteric Disease Testing Market, By Country
o ChinaPCR-based Enteric Disease Testing Market
o Japan PCR-based Enteric Disease Testing Market
o South KoreaPCR-based Enteric Disease Testing Market
o India PCR-based Enteric Disease Testing Market
o Southeast AsiaPCR-based Enteric Disease Testing Market
o Rest of Asia-Pacific PCR-based Enteric Disease Testing Market
o South America
§ South AmericaPCR-based Enteric Disease Testing Market
o Brazil PCR-based Enteric Disease Testing Market
o ArgentinaPCR-based Enteric Disease Testing Market
o ColumbiaPCR-based Enteric Disease Testing Market
o Rest of South America PCR-based Enteric Disease Testing Market
o Middle East and Africa
§ Middle East and AfricaPCR-based Enteric Disease Testing Market
o Saudi ArabiaPCR-based Enteric Disease Testing Market
o UAEPCR-based Enteric Disease Testing Market
o EgyptPCR-based Enteric Disease Testing Market
o NigeriaPCR-based Enteric Disease Testing Market
o South Africa PCR-based Enteric Disease Testing Market
o Rest of MEA PCR-based Enteric Disease Testing Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. PCR-based Enteric Disease Testing Market, By Type
5.1. Introduction
5.2. Global PCR-based Enteric Disease Testing Revenue and Market Share by Type (2017-2021)
5.2.1. Global PCR-based Enteric Disease Testing Revenue and Revenue Share by Type (2017-2021)
5.3. Analyzers/Instruments
5.3.1. Global Analyzers/Instruments Revenue and Growth Rate (2017-2021)
5.4. Kits/Panels
5.4.1. Global Kits/Panels Revenue and Growth Rate (2017-2021)
6. PCR-based Enteric Disease Testing Market, By Application
6.1. Introduction
6.2. Global PCR-based Enteric Disease Testing Revenue and Market Share by Application (2017-2021)
6.2.1. Global PCR-based Enteric Disease Testing Revenue and Revenue Share by Application (2017-2021)
6.3. Clostridium Difficile
6.3.1. Global Clostridium Difficile Revenue and Growth Rate (2017-2021)
6.4. Campylobacteriosis
6.4.1. Global Campylobacteriosis Revenue and Growth Rate (2017-2021)
6.5. Cholera
6.5.1. Global Cholera Revenue and Growth Rate (2017-2021)
6.6. E. coli Infection
6.6.1. Global E. coli Infection Revenue and Growth Rate (2017-2021)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2021)
7. PCR-based Enteric Disease Testing Market, By Region
7.1. Introduction
7.2. Global PCR-based Enteric Disease Testing Revenue and Market Share by Regions
7.2.1. Global PCR-based Enteric Disease Testing Revenue by Regions (2017-2021)
7.3. North America PCR-based Enteric Disease Testing by Countries
7.3.1. North America PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2021)
7.3.2. North America PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe PCR-based Enteric Disease Testing by Countries
7.4.1. Europe PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2021)
7.4.2. Europe PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific PCR-based Enteric Disease Testing by Countries
7.5.1. Asia-Pacific PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America PCR-based Enteric Disease Testing by Countries
7.6.1. South America PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2021)
7.6.2. South America PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa PCR-based Enteric Disease Testing by Countries
7.7.1. Middle East and Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Thermo Fisher Scientific
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Vela Diagnostics
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. CorisBioconcept
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Meridian Life Science
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bio-Rad Laboratories
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Abbott (ALERE)
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. bioMerieux SA
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Trinity Biotech
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. DiaSorin Molecular
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Etta Healthcare (Ovagene Oncology)
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.1. Global PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. PCR-based Enteric Disease Testing Market Forecast by Regions (2022-2027)
9.2.1. North America PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.1.1. United States PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.1.2. Canada PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.1.3. Mexico PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2. Europe PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.1. Germany PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.2. France PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.3. UK PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.4. Russia PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.5. Italy PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.2.6. Rest of Europe PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3. Asia-Pacific PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.1. China PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.2. Japan PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.3. Korea PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.4. India PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.5. Southeast Asia PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.4. South America PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.4.1. Brazil PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.4.2. Argentina PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.4.3. Columbia PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.4.4. Rest of South America PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5. Middle East and Africa PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.3. Egypt PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.4. Nigeria PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.5. South Africa PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.6. Turkey PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa PCR-based Enteric Disease Testing Market Forecast (2022-2027)
9.3. PCR-based Enteric Disease Testing Market Forecast by Type (2022-2027)
9.3.1. PCR-based Enteric Disease Testing Forecast by Type (2022-2027)
9.3.2. PCR-based Enteric Disease Testing Market Share Forecast by Type (2022-2027)
9.4. PCR-based Enteric Disease Testing Market Forecast by Application (2022-2027)
9.4.1. PCR-based Enteric Disease Testing Forecast by Application (2022-2027)
9.4.2. PCR-based Enteric Disease Testing Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global PCR-based Enteric Disease Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global Analyzers/Instruments Revenue and Growth Rate (2017-2019)
Figure Global Kits/Panels Revenue and Growth Rate (2017-2019)
Table Global PCR-based Enteric Disease Testing Revenue and Revenue Share by Application (2017-2019)
Figure Global Clostridium Difficile Revenue and Growth Rate (2017-2019)
Figure Global Campylobacteriosis Revenue and Growth Rate (2017-2019)
Figure Global Cholera Revenue and Growth Rate (2017-2019)
Figure Global E. coli Infection Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global PCR-based Enteric Disease Testing Revenue by Regions (2017-2019)
Figure North America PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure North America PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2019)
Figure North America PCR-based Enteric Disease Testing by Countries (2017-2019)
Figure North America PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure United States PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Canada PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Mexico PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Europe PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2019)
Figure Europe PCR-based Enteric Disease Testing by Countries (2017-2019)
Figure Europe PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Germany PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure France PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure UK PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Russia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Italy PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Rest of Europe PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Asia-Pacific PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific PCR-based Enteric Disease Testing by Countries (2017-2019)
Figure Asia-Pacific PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2019)
Figure China PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure China PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Japan PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Korea PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure India PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Southeast Asia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure South America PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2019)
Figure South America PCR-based Enteric Disease Testing by Countries (2017-2019)
Figure South America PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Brazil PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Argentina PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Columbia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Rest of South America PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Middle East and Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa PCR-based Enteric Disease Testing by Countries (2017-2019)
Figure Middle East and Africa PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Saudi Arabia PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure United Arab Emirates PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Egypt PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Nigeria PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure South Africa PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Turkey PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR-based Enteric Disease Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Thermo Fisher Scientific PCR-based Enteric Disease Testing Financial Overview
Table Vela Diagnostics PCR-based Enteric Disease Testing Financial Overview
Table CorisBioconcept PCR-based Enteric Disease Testing Financial Overview
Table Meridian Life Science PCR-based Enteric Disease Testing Financial Overview
Table Bio-Rad Laboratories PCR-based Enteric Disease Testing Financial Overview
Table Abbott (ALERE) PCR-based Enteric Disease Testing Financial Overview
Table bioMerieux SA PCR-based Enteric Disease Testing Financial Overview
Table Trinity Biotech PCR-based Enteric Disease Testing Financial Overview
Table DiaSorin Molecular PCR-based Enteric Disease Testing Financial Overview
Table Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Financial Overview
Figure Global PCR-based Enteric Disease Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table PCR-based Enteric Disease Testing Market Forecast by Regions (2019-2027)
Figure North America PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure United States PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Canada PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Mexico PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Europe PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Germany PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure France PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure UK PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Russia PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Italy PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Rest of Europe PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Asia-Pacific PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure China PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Japan PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Korea PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure India PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Southeast Asia PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure South America PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Brazil PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Argentina PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Columbia PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Rest of South America PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Middle East and Africa PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Saudi Arabia PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure United Arab Emirates PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Egypt PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Nigeria PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure South Africa PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Turkey PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa PCR-based Enteric Disease Testing Market Forecast (2019-2027)
Figure Global PCR-based Enteric Disease Testing Forecast by Type (2019-2027)
Figure Global PCR-based Enteric Disease Testing Market Share Forecast by Type (2019-2027)
Figure Global PCR-based Enteric Disease Testing Forecast by Type (2019-2027)
Figure Global PCR-based Enteric Disease Testing Forecast by Application (2019-2027)
Figure Global PCR-based Enteric Disease Testing Market Share Forecast by Application (2019-2027)
Figure Global PCR-based Enteric Disease Testing Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|